All data are based on the daily closing price as of May 12, 2026
a

ASKA Pharmaceutical Holdings

4886.TSE
17.44 USD
-1.03
-5.58%

Overview

Last close
17.44 usd
Market cap
495.16M usd
52 week high
18.73 usd
52 week low
11.96 usd
Target price
15.86 usd

Valuation

P/E
14.3694
Forward P/E
N/A
Price/Sales
1.0971
Price/Book Value
1.2117
Enterprise Value
573.76M usd
EV/Revenue
1.3491
EV/EBITDA
10.8066

Key financials

Revenue TTM
451.34M usd
Gross Profit TTM
216.67M usd
EBITDA TTM
51.28M usd
Earnings per Share
1.21 usd
Dividend
N/A usd
Total assets
719.62M usd
Net debt
51.26M usd

About

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, imports, exports, and sells veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers quasi-drugs, food supplements, and medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.
  • Symbol
    4886.TSE
  • Exchange
    TSE
  • Isin
    JP3119660003
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Tokyo
  • Web site
    https://www.aska-pharma-hd.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top